Height protein could be cancer and diabetes treatment target

by Bronwyn Adams
Height protein could be cancer and diabetes treatment target
Dr Andrew Brooks and Professor Mike Waters

University of Queensland scientists have discovered that a protein that regulates how tall you grow could be used in treating diseases including cancer and diabetes.

Growth hormone, acting through its receptor, determines whether you are struggling to reach high shelves or bumping your head on doorways.

Researchers from UQ's Institute for Molecular Bioscience, led by Professor Mike Waters, have now found it is also an untapped target for drugs.

"People without don't die from cancer or diabetes, making it an ideal drug target," Professor Waters said.

"But we didn't know enough about how it functioned to be able to design cancer or that would bind to the receptor and turn it either on or off as appropriate.

"We've now figured out how growth hormone turns on its receptor at the molecular level, and so have a clear idea of which part of the molecule to target to design drugs to combat these diseases."

This is the culmination of 45 years of work studying growth hormone for Professor Waters, who originally cloned the receptor with Genentech, one of the world's leading biotechnology companies.

The discovery was published overnight in Science.

Dr Andrew Brooks, who led the study with Professor Waters, said the discovery had implications beyond cancer and diabetes.

"Growth is one of a group of proteins known as cytokine receptors, which are important targets for therapeutics for a range of disorders, including , blood disorders, osteoporosis and obesity," Dr Brooks said.

"Our understanding of how receptor functions should give us insights into how the other cytokine receptors work, which in turn will inform the design of therapeutics to target these cytokine receptors and to treat many diseases."

More information: Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor, Science, 2014.

add to favorites email to friend print save as pdf

Related Stories

Target for obesity drugs comes into focus

Oct 11, 2012

(Medical Xpress)—Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.

Recommended for you

Team finds key signaling pathway in cause of preeclampsia

5 hours ago

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

9 hours ago

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments